Subscribe To
In8bio to present new positive data from phase 1 trial of inb-100 at 2023 american society of hematology (ash) annual meeting
NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta ...
November 2, 2023, 9:17 am
Corvus pharmaceuticals to present new interim soquelitinib data from its phase 1/1b t cell lymphoma trial at the 65th american society of hematology (ash) annual meeting & exposition
BURLINGAME, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today ...
November 2, 2023, 9:15 am
Agios pharmaceuticals to present broad set of clinical and translational data in rare blood disorders at 65th ash annual meeting and exposition
– Both Mitapivat Dose Arms Achieved Statistically Significant Hemoglobin Response in Phase 2 Portion of RISE UP Pivotal Study in Sickle Cell Disease...
November 2, 2023, 9:05 am
Molecular partners to present initial data from ongoing phase 1/2a trial of mp0533 for patients with relapsed/refractory aml and aml/mds at the 65th ash annual meeting and exposition
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (...
November 2, 2023, 2:00 am
Nobleai’s science-based ai technology to be highlighted at spe annual technical conference and exposition
How Use of AI-Powered Modeling Sped Multi-Well and Multi-Bench Unconventional Development for ExxonMobil SAN FRANCISCO, Oct. 12, 2023 (GLOBE NEWSWIRE)...
October 12, 2023, 12:05 pm
Herbalife scientists to present on green chemistry practices and ingredient testing innovations at 2023 aoac international annual meeting and exposition
Herbalife's Director of Quality Control Lab, Quanyin Gao, appointed to AOAC Technical Programming Council LOS ANGELES , Aug. 24, 2023 /PRNewswire/ ...
August 24, 2023, 2:08 pm
Bectran to exhibit cutting-edge credit management solutions at credit congress & expo 2023
Meet Bectran’s Experts at Booth 318/320 to Explore Our Automated Credit, Collections and Accounts Receivable Solutions. CHICAGO, June 06, 2023 (GLOB...
June 6, 2023, 7:38 pm
Uncle budd nyc makes historic debut as new york’s first black-owned cannabis brand at cwcb expo 2023
Transforming the Cannabis Industry: Uncle Budd’s Journey from Adversity to Innovation Empowers Communities and Advocates for Social Equity New York,...
May 31, 2023, 10:52 pm
Associa executives to present at 2023 cai annual conference
DALLAS, May 15, 2023 (GLOBE NEWSWIRE) — Associa, the community management industry’s largest company, is pleased to announce that three of its exe...
May 15, 2023, 5:44 pm
Hr technology conference & exposition® expands global footprint with europe event in 2024
World’s Longest-Running Event on HR Innovation Coming to Amsterdam PALM BEACH GARDENS, Fla., April 26, 2023 (GLOBE NEWSWIRE) — Today, the Human Re...
April 26, 2023, 11:00 am
Expo chicago and the magnificent mile® association, with kavi gupta gallery, to present third iteration of skin + masks, curated by acclaimed artist vic mens
Centering on Work by Emerging Chicago-Based Contemporary Artists, SKIN + MASKS Seeks to Explore the Meaning of Identity and Will Be on View through Ap...
December 13, 2022, 6:07 pm
Agios presents updated pyrukynd® (mitapivat) long-term extension data demonstrating sustained clinical benefits in adults with pyruvate kinase (pk) deficiency at 64th ash annual meeting and exposition
– Data Suggest Long-term Treatment with PYRUKYND® in Adults with PK Deficiency is Associated with Improvements in Hemoglobin, Iron Overload, Transf...
December 12, 2022, 12:00 am
Bellicum announces presentation by unc at ash 2022 on potential abrogation of ic9 car t-cell toxicities with rimiducid
HOUSTON, Dec. 11, 2022 (GLOBE NEWSWIRE) — Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a leader in developing novel, controllable cellular immunot...
December 11, 2022, 3:00 pm
Vertex and crispr therapeutics to present at the american society of hematology (ash) annual meeting and exposition
BOSTON and ZUG, Switzerland--( BUSINESS WIRE )--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) today announ...
December 10, 2022, 8:00 am
In8bio to present positive early data from ongoing phase 1 study of inb-100 at the 64th american society of hematology annual meeting
NEW YORK, Nov. 03, 2022 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company discovering and developing innovat...
November 3, 2022, 9:10 am
Harpoon therapeutics to present interim results from phase 1 clinical trial of t cell engager hpn217 at the 64th ash annual meeting and exposition
Updated interim results from Phase 1 clinical trial of HPN217 in heavily pretreated patients with relapsed/refractory multiple myeloma to be presented...
November 3, 2022, 9:09 am
2seventy bio to present data from karmma-2 study of abecma (idecabtagene vicleucel) at the 64th american society of hematology (ash) annual meeting and exposition
CAMBRIDGE, Mass....
November 3, 2022, 9:06 am
General dynamics at ausa 2021: transforming america's future fighting force
RESTON, Va., Oct. 6, 2021 /PRNewswire/ -- Four business units of General Dynamics (NYSE:GD) will participate in the Association of the U.S. Army's 20...
October 6, 2021, 2:30 pm
General dynamics at ausa 2021: transforming america's future fighting force
RESTON, Va., Oct. 6, 2021 /PRNewswire/ -- Four business units of General Dynamics (NYSE:GD) will participate in the Association of the U.S. Army's 20...
October 6, 2021, 2:30 pm
General dynamics at ausa 2021: transforming america's future fighting force
RESTON, Va., Oct. 6, 2021 /PRNewswire/ -- Four business units of General Dynamics (NYSE:GD) will participate in the Association of the U.S. Army's 20...
October 6, 2021, 2:30 pm